Cargando…

Hypofractionated Radiotherapy in African Cancer Centers

In the advent of the coronavirus disease (COVID-19) pandemic, professional societies including the American Society for Radiation Oncology and the National Comprehensive Cancer Network recommended adopting evidence-based hypofractionated radiotherapy (HFRT). HFRT benefits include reduction in the nu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swanson, William, Kamwa, Francesca, Samba, Richard, Ige, Taofeeq, Lasebikan, Nwamaka, Mallum, Abba, Ngoma, Twalib, Sajo, Erno, Elzawawy, Ahmed, Incrocci, Luca, Ngwa, Wilfred
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933544/ https://www.ncbi.nlm.nih.gov/pubmed/33680940 http://dx.doi.org/10.3389/fonc.2020.618641

Ejemplares similares

Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in Africa
por: Swanson, William, et al.
Publicado: (2021)

Can the Adoption of Hypofractionation Guidelines Expand Global Radiotherapy Access? An Analysis for Breast and Prostate Radiotherapy
por: Irabor, Omoruyi Credit, et al.
Publicado: (2020)

Expanding radiotherapy access in Sub-Saharan Africa: an analysis of travel burdens and patient-related benefits of hypofractionation
por: Patel, Saloni, et al.
Publicado: (2023)

Challenges and opportunities for implementing hypofractionated radiotherapy in Africa: lessons from the HypoAfrica clinical trial
por: Olatunji, Elizabeth, et al.
Publicado: (2023)

Cancer and COVID-19 Experiences at African Cancer Centers: The Silver Lining
por: Grossheim, Linda, et al.
Publicado: (2021)

Using advanced information and communication technologies to advance oncology education in Africa
por: Asana, Lydia, et al.
Publicado: (2021)

Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020)

The Role of Positron Emission Tomography and Computed Tomographic (PET/CT) Imaging for Radiation Therapy Planning: A Literature Review
por: Mallum, Abba, et al.
Publicado: (2022)

Mobilising stakeholders to improve access to state-of-the-art radiotherapy in low- and middle-income countries
por: Chofor, Ndimofor, et al.
Publicado: (2021)

Smart Radiotherapy Biomaterials for Image-Guided In Situ Cancer Vaccination
por: Ainsworth, Victoria, et al.
Publicado: (2023)

Optimizing In Situ Vaccination During Radiotherapy
por: Yasmin-Karim, Sayeda, et al.
Publicado: (2021)

Evolution of Hypofractionated Accelerated Radiotherapy for Prostate Cancer – The Sunnybrook Experience
por: Musunuru, Hima Bindu, et al.
Publicado: (2014)

An Extended Hypofractionated Palliative Radiotherapy Regimen for Head and Neck Carcinomas
por: Laursen, Michael, et al.
Publicado: (2018)

Hypofractionated Radiotherapy for Palliation of Main Portal Vein Tumor Thrombosis
por: Fang, Fang, et al.
Publicado: (2022)

Challenges and Opportunities for Increasing Adoption of Hypofractionated Radiotherapy in Low- and Middle-Income Countries
por: Joseph, A.O., et al.
Publicado: (2022)

Phytoradiotherapy: An Integrative Approach to Cancer Treatment by Combining Radiotherapy With Phytomedicines
por: Alfonzetti, Tyler, et al.
Publicado: (2021)

Real-World Practice of Hypofractionated Radiotherapy in Patients With Invasive Breast Cancer
por: Chen, Fang, et al.
Publicado: (2022)

Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
por: Arpa, Donatella, et al.
Publicado: (2021)

Nanoparticle-based radiotherapy: Is dose all that matters?
por: Zygmanski, Piotr, et al.
Publicado: (2023)

Safety measures in selected radiotherapy centres within Africa in the face of Covid-19
por: Hasford, Francis, et al.
Publicado: (2020)

Hypofractionated Radiotherapy in Head and Neck Cancer Elderly Patients: A Feasibility and Safety Systematic Review for the Clinician
por: Piras, Antonio, et al.
Publicado: (2021)

Effectiveness of hypofractionated and normofractionated radiotherapy in a triple‐negative breast cancer model
por: Grosche, Sinja, et al.
Publicado: (2022)

Robustness of hypofractionated breast radiotherapy after breast-conserving surgery with free breathing
por: Chen, Kunzhi, et al.
Publicado: (2023)

Short Course Hypofractionated Radiotherapy for Frail or Elderly Patients With Meningioma
por: Sarhan, Nasim, et al.
Publicado: (2020)

A liquid immunogenic fiducial eluter for image-guided radiotherapy
por: Moreau, Michele, et al.
Publicado: (2022)

Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme
por: Greer, Liana, et al.
Publicado: (2017)

Nivolumab and Hypofractionated Radiotherapy in Patients With Advanced Lung Cancer: ABSCOPAL-1 Clinical Trial
por: Ye, Hua, et al.
Publicado: (2021)

Automated prediction of dosimetric eligibility for hypofractionated prostate radiotherapy
por: Lausch, Anthony, et al.
Publicado: (2017)

Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer
por: He, Jiaoxue, et al.
Publicado: (2023)

Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidance
por: Hafeez, Shaista, et al.
Publicado: (2020)

Dosimetric Impact of the Positional Imaging Frequency for Hypofractionated Prostate Radiotherapy – A Voxel-by-Voxel Analysis
por: Splinter, Mona, et al.
Publicado: (2020)

Quantitative MRI Changes During Weekly Ultra-Hypofractionated Prostate Cancer Radiotherapy With Integrated Boost
por: van Schie, Marcel A., et al.
Publicado: (2019)

Automated and robust beam data validation of a preconfigured ring gantry linear accelerator using a 1D tank with synchronized beam delivery and couch motions
por: Knutson, Nels C., et al.
Publicado: (2020)

Tracheal Diverticulum Following Paratracheal Hypofractionated Radiotherapy in the Setting of Prior and Subsequent Bevacizumab
por: Chaudhuri, Aadel A, et al.
Publicado: (2016)

Phase II Trial of Pure Hypofractionated Radiotherapy in the Treatment of Localized Carcinoma of the Prostate
por: Gopaul, Darin, et al.
Publicado: (2018)

Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy
por: Patel, Mira A., et al.
Publicado: (2017)

Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis
por: Yan, Michael, et al.
Publicado: (2022)

Comparison of Local Recurrence Among Early Breast Cancer Patients Treated With Electron Intraoperative Radiotherapy vs Hypofractionated Photon Radiotherapy an Observational Study
por: Guenzi, Marina, et al.
Publicado: (2018)

Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants
por: Moreau, Michele, et al.
Publicado: (2018)

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years
por: Aujla, Khush S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ejvu8nbq7m1c639gq64autg64g